# Study of Metronidazole Delayed-Release Capsules in Comparison With Immediate-Release Tablets (Flagyl) for Safety and Pharmacokinetics

> **NCT07251127** · PHASE1 · COMPLETED · sponsor: **Gateway Pharmaceutical LLC** · enrollment: 18 (actual)

## Conditions studied

- Clostridium Difficile Infection (CDI)

## Interventions

- **DRUG:** Delayed-release metronidazole
- **DRUG:** Immediate-release metronidazole

## Key facts

- **NCT ID:** NCT07251127
- **Lead sponsor:** Gateway Pharmaceutical LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-27
- **Primary completion:** 2025-06-06
- **Final completion:** 2025-06-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07251127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07251127, "Study of Metronidazole Delayed-Release Capsules in Comparison With Immediate-Release Tablets (Flagyl) for Safety and Pharmacokinetics". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07251127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*